Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) An erratum has been published Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Smith-Vaughan, H. C. Articles by Currie, B. J. Search for Related Content PubMed PubMed Citation Articles by Smith-Vaughan, H. C. Articles by Currie, B. J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 2003, p. 883-885, Vol. 41, No. 2
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.2.883-885.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Ubiquity of Putative Type III Secretion Genes among Clinical and Environmental Burkholderia pseudomallei Isolates in Northern Australia

H. C. Smith-Vaughan,^1* D. Gal,¹ P. M. Lawrie,² C. Winstanley,³ K. S. Sriprakash,⁴ and B. J. Currie¹

University of Queensland,² Queensland Institute of Medical Research, Brisbane,⁴ Menzies School of Health Research, Royal Darwin Hospital, Darwin, Australia,¹ Department of Medical Microbiology and Genitourinary Medicine, University of Liverpool, Liverpool, United Kingdom³

Received 22 July 2002/ Returned for modification 22 October 2002/ Accepted 22 November 2002

Top Abstract Text References

 
Horseradish peroxidase-like type III secretion (TTS1) genes were present in all 116 Northern Australian Burkholderia pseudomallei isolates tested but were not detected in other common environmental Burkholderia species. PCR of TTS1 genes may prove valuable as a diagnostic test.

Top Abstract Text References

 
Melioidosis is potentially a life-threatening disease and is endemic in Northern Australia and Southeast Asia (5). The etiological agent of melioidosis, Burkholderia pseudomallei, is a soil- and water-dwelling saprophyte capable of causing catastrophic systemic infections in humans and animals (7). Melioidosis is now recognized as the most common cause of fatal community-acquired bacteremic pneumonia in two hyperendemic regions, northeastern Thailand and the Top End of the Northern Territory of Australia (5).

An intriguing difference in melioidosis epidemiology in these two regions where melioidosis is hyperendemic is the lack of correlation between disease incidence and seropositivity in the respective populations. The average annual incidence of melioidosis in the Top End is 16.5 out of 100,000 (34.5 out of 100,000 in the heavy 1998 monsoonal season) with seropositivity ranging between 5 and 13% (5). In comparison, the annual incidence in Ubon Ratchathani in northeastern Thailand is 4.4 out of 100,000, where the majority of the rural population is seropositive (15). Several explanations may account for these observations. In Thailand, underreporting of cases and protective immunity resulting from recurrent exposure may be factors, whereas in the Top End, a higher prevalence of risk factors for disease, such as diabetes and alcohol excess, and/or the presence of more virulent strains may be important (5). Indeed, different isolates appear to have various levels of pathogenicity, as demonstrated in animal models and epidemiological studies. For example, the 50% lethal dose of 42 Australian and Papua New Guinean isolates ranged from 10 CFU to the least virulent of >10⁶ CFU in B. pseudomallei-susceptible BALB/c mice (17). Furthermore, our studies with isolates from a goat farm demonstrated that the predominant B. pseudomallei clone causing disease in the goats was underrepresented in the soil, while the common soil clones were rarely cultured from goats with melioidosis (unpublished data).

Many different approaches are presently under way to elucidate the mechanisms of B. pseudomallei pathogenesis, and several factors have been identified to date (10, 12, 18, 21). Recently, the presence of type III secretion (TTS)-associated genes in B. pseudomallei was described (1, 19, 20). A variety of gram-negative pathogens of animals and plants can use TTS systems to deliver virulence factors to host cells. The range of diseases caused by these pathogens in different hosts is reflected in the myriad of type III-secreted proteins (9). Winstanley et al. (19) identified a cluster of genes in B. pseudomallei with high similarity to genes of a horseradish peroxidase (hypersensitivity response and pathogenicity) locus in Ralstonia solanacearum and developed probes targeting a corresponding region in B. pseudomallei. Furthermore, mining of the B. pseudomallei genome has been used to identify a second related TTS gene cluster (11) and a region resembling the SPI-1 locus of Salmonella enterica serovar Typhimurium, including putative homologues of the effectors SipB and SopE which may be involved in apoptosis, cell fusion, and actin-associated membrane protrusion (1). PCR and genome sequence analyses indicate that, unlike the 50% lethal dose-like TTS cluster (TTS1), the other two TTS gene clusters are also present in Burkholderia thailandensis and Burkholderia mallei (11).

In this study, 116 clinical and environmental B. pseudomallei isolates collected in the Top End were screened for TTS1 genes. Some of these isolates exhibited relatively low virulence in mouse models and/or colonized patients without apparent disease. Environmental isolates were cultured from soil and water samples collected from various outback communities and rural and urban properties in the Top End by using Ashdown's medium (2). Environmental B. pseudomallei organisms were identified by using an API 20E (bioMerieux, Marcy l'Etoile, France), polyclonal antibody-based latex agglutination, and diagnostic PCR (8). Clinical isolates were identified by MicroScan Walkaway (Dade Diagnostics, Calif.), and veterinary isolates were identified by GN MicroPlate (Biolog, Calif.). Genomic DNA was extracted from Burkholderia strains (3), and TTS1 genes were amplified by using conditions previously described (20). For the detection of TTS1 genes by Southern blotting and hybridization, samples of 1 µg of genomic DNA cut with EcoRI were electrophoresed on a 0.8% agarose gel (13). The probe was prepared by PCR amplification by using the primers described previously (20) and a cosmid clone containing the TTS1 genes as a template. The amplicon was labeled through five additional PCR cycles with [-³²P]dATP. All methods used were as described previously (13). L-arabinose assimilation was determined by using GN MicroPlate, MicroScan Walkaway, or API 20E. Early isolates for which biochemical profiles were not available were tested on minimal agar medium supplemented with 0.2% (wt/vol) L-arabinose as described previously (16).

None of the Top End human, veterinary, and environmental B. pseudomallei isolates in this study assimilated L-arabinose (Ara^-); in fact, no Ara⁺ strains (B. thailandensis) have been detected in Australia to date. PCR amplification of TTS1 genes was performed on 116 Top End B. pseudomallei isolates, 12 B. thailandensis isolates from Thailand, and a further 7 isolates of other Burkholderia species (Table 1 and Fig. 1). All human, environmental, and veterinary B. pseudomallei isolates from the Top End were positive for TTS1 genes by PCR. Other Burkholderia species (B. cepacia, B. spinosa, and B. vietnamiensis) commonly encountered by our laboratory in environmental specimens and the B. thailandensis isolates were negative by this test. These results were confirmed by Southern hybridization with the TTS1-specific probe (data not shown).

View this table: [in this window] [in a new window]

TABLE 1. TTS1 PCR results

View larger version (102K): [in this window] [in a new window]

FIG. 1. TTS1 PCR results. Lane 1, X174 HinfI; lane 2, B. thailandensis; lane 3, Northern Territory human clinical B. pseudomallei; lane 4, Northern Territory veterinary B. pseudomallei; lane 5, Northern Territory soil B. pseudomallei; lane 6, Northern Territory water B. pseudomallei; lane 7, B. cepacia; lane 8, B. spinosa; lane 9, B. vietnamiensis; lane 10, X174 HinfI.

The ability of a strain of B. pseudomallei to cause clinical illness and the severity of the infection is undoubtedly related to host factors. In the Top End, 80% of melioidosis cases were identified as having one or more associated risk factors, including excessive alcohol consumption (39%), diabetes (37%), chronic lung disease (27%), chronic renal disease (10%), and other risk factors (20%) (4). Furthermore, all but 1 of the 49 fatal cases had at least one identified risk factor (4).

Nevertheless, results from several studies suggest that host factors are not alone in determining the onset and severity of melioidosis and that virulence levels vary between strains of B. pseudomallei. Further variables, including inoculating dose, time between infection and presentation, and the adequacy of treatment can influence clinical severity of melioidosis (17). Our finding that all isolates contained TTS1 genes could not explain the reported variations in virulence among Top End isolates in BALB/c mice (17).

An important marker of B. pseudomallei virulence is its inability to utilize L-arabinose as a sole energy source (Ara^-). In contrast, the antigenically cross-reacting Ara⁺ B. thailandensis strains rarely cause disease (6, 16). Regional mapping of soils across Thailand demonstrated a correlation between the Ara^-/Ara⁺ ratio in environmental isolates and incidence of melioidosis; a ratio of 1.7 in the northeastern hyperendemic region compared to 0.4 in central Thailand, where melioidosis cases are uncommon (16). To date, all Top End environmental B. pseudomallei isolates have proven to be Ara^- (5), which is consistent with the higher incidence of melioidosis in this region. Quantitative counts of environmental B. pseudomallei have also been correlated with disease incidence (14) and may play a role in this region.

In conclusion, TTS1 genes appear to be ubiquitous among Top End clinical and environmental strains of B. pseudomallei. This is consistent with its environmental existence and its relationship with plant hosts. The TTS1 amplicon was not present in other environmental Burkholderia species commonly encountered by our laboratory. Thus, PCR for TTS1 may prove highly useful for primary identification of B. pseudomallei in environmental samples. We are presently investigating its general applicability for diagnostic PCR.

 
We are grateful to Royal Darwin Hospital microbiology staff for providing clinical isolates, Kevin Fomiatti and the Department of Primary Industries and Fisheries in Darwin for providing veterinary isolates and undertaking BioLog testing, and V. Wuthiekanun of Mahidol University, Bangkok, Thailand, for providing B. thailandensis isolates. We are also thankful to the owners of land at outback communities and rural and urban properties in the Top End and in Crocodylus Park, Darwin, for their interest in our studies and for allowing us to test soil on their lands.

The National Health and Medical Research Council (Australia) and Wellcome Trust (United Kingdom) provided support for this project.

 
* Corresponding author. Mailing address: Menzies School of Health Research, Building 58, Royal Darwin Hospital, Rocklands Dr., Tiwi, 0810, Darwin, Australia. Phone: 61-889-228196. Fax: 61-889-275187. E-mail: heidi{at}menzies.edu.au.

Top Abstract Text References

 

1
1. Attree, O., and I. Attree. 2001. A second type III secretion system in Burkholderia pseudomallei: who is the real culprit? Microbiology 147:3197-3199.[Free Full Text]
2
2. Brook, M. D., B. Currie, and P. M. Desmarchelier. 1997. Isolation and identification of Burkholderia pseudomallei from soil using selective culture techniques and the polymerase chain reaction. J. Appl. Microbiol. 82:589-596.[Medline]
3
3. Currie, B., H. Smith-Vaughan, C. Golledge, N. Buller, K. S. Sriprakash, and D. J. Kemp. 1994. Pseudomonas pseudomallei isolates collected over 25 years from a non-tropical endemic focus show clonality on the basis of ribotyping. Epidemiol. Infect. 113:307-312.[Medline]
4
4. Currie, B. J., D. A. Fisher, D. M. Howard, J. N. Burrow, D. Lo, S. Selva-Nayagam, N. M. Anstey, S. E. Huffam, P. L. Snelling, P. J. Marks, D. P. Stephens, G. D. Lum, S. P. Jacups, and V. L. Krause. 2000. Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin. Infect. Dis. 31:981-986.[CrossRef][Medline]
5
5. Currie, B. J., D. A. Fisher, D. M. Howard, J. N. Burrow, S. Selvanayagam, P. L. Snelling, N. M. Anstey, and M. J. Mayo. 2000. The epidemiology of melioidosis in Australia and Papua New Guinea. Acta Trop. 74:121-127.[CrossRef][Medline]
6
6. Dance, D. A. 2000. Ecology of Burkholderia pseudomallei and the interactions between environmental Burkholderia spp. and human-animal hosts. Acta Trop. 74:159-168.[CrossRef][Medline]
7
7. Dance, D. A. B. 1991. Melioidosis: the tip of the iceberg? Clin. Microbiol. Rev. 4:52-60.[Abstract/Free Full Text]
8
8. Dharakul, T., S. Songsivilai, S. Viriyachitra, V. Luangwedchakarn, B. Tassaneetritap, and W. Chaowagul. 1996. Detection of Burkholderia pseudomallei DNA in patients with septicemic melioidosis. J. Clin. Microbiol. 34:609-614.[Abstract]
9
9. Hueck, C. J. 1998. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 62:379-433.[Abstract/Free Full Text]
10
10. Loprasert, S., R. Sallabhan, W. Whangsuk, and S. Mongkolsuk. 2000. Characterization and mutagenesis of fur gene from Burkholderia pseudomallei. Gene 254:129-137.[CrossRef][Medline]
11
11. Rainbow, L., C. A. Hart, and C. Winstanley. 2002. Distribution of type III secretion gene clusters in Burkholderia pseudomallei, B. thailandensis and B. mallei. J. Med. Microbiol. 51:374-384.[Abstract/Free Full Text]
12
12. Reckseidler, S. L., D. DeShazer, P. A. Sokol, and D. E. Woods. 2001. Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant. Infect. Immun. 69:34-44.[Abstract/Free Full Text]
13
13. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
14
14. Smith, M. D., V. Wuthiekanun, A. L. Walsh, and N. J. White. 1995. Quantitative recovery of Burkholderia pseudomallei from soil in Thailand. Trans. R. Soc. Trop. Med. Hyg. 89:488-490.[CrossRef][Medline]
15
15. Suputtamongkol, Y., A. J. Hall, D. A. Dance, W. Chaowagul, A. Rajchanuvong, M. D. Smith, and N. J. White. 1994. The epidemiology of melioidosis in Ubon Ratchatani, northeast Thailand. Int. J. Epidemiol. 23:1082-1090.[Abstract/Free Full Text]
16
16. Trakulsomboon, S., V. Vuddhakul, P. Tharavichitkul, N. Na-Gnam, Y. Suputtamongkol, and V. Thamlikitkul. 1999. Epidemiology of arabinose assimilation in Burkholderia pseudomallei isolated from patients and soil in Thailand. Southeast Asian J. Trop. Med. Public Health 30:756-759.[Medline]
17
17. Ulett, G. C., B. J. Currie, T. W. Clair, M. Mayo, N. Ketheesan, J. Labrooy, D. Gal, R. Norton, C. A. Smith, J. Barnes, J. Warner, and R. G. Hirst. 2001. Burkholderia pseudomallei virulence: definition, stability and association with clonality. Microbes Infect. 3:621-631.[CrossRef][Medline]
18
18. Utaisincharoen, P., N. Tangthawornchaikul, W. Kespichayawattana, P. Chaisuriya, and S. Sirisinha. 2001. Burkholderia pseudomallei interferes with inducible nitric oxide synthase (iNOS) production: a possible mechanism of evading macrophage killing. Microbiol. Immunol. 45:307-313.[Medline]
19
19. Winstanley, C., B. A. Hales, and C. A. Hart. 1999. Evidence for the presence in Burkholderia pseudomallei of a type III secretion system-associated gene cluster. J. Med. Microbiol. 48:649-656.[Abstract/Free Full Text]
20
20. Winstanley, C., and C. A. Hart. 2000. Presence of type III secretion genes in Burkholderia pseudomallei correlates with Ara^- phenotypes. J. Clin. Microbiol. 38:883-885.[Abstract/Free Full Text]
21
21. Woods, D. E., D. DeShazer, R. A. Moore, P. J. Brett, M. N. Burtnick, S. L. Reckseidler, and M. D. Senkiw. 1999. Current studies on the pathogenesis of melioidosis. Microbes Infect. 1:157-162.[CrossRef][Medline]

---

Journal of Clinical Microbiology, February 2003, p. 883-885, Vol. 41, No. 2
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.2.883-885.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Kaestli, M., Mayo, M., Harrington, G., Watt, F., Hill, J., Gal, D., Currie, B. J. (2007). Sensitive and Specific Molecular Detection of Burkholderia pseudomallei, the Causative Agent of Melioidosis, in the Soil of Tropical Northern Australia. Appl. Environ. Microbiol. 73: 6891-6897 [Abstract] [Full Text]  
• Ekpo, P., Rungpanich, U., Pongsunk, S., Naigowit, P., Petkanchanapong, V. (2007). Use of Protein-Specific Monoclonal Antibody-Based Latex Agglutination for Rapid Diagnosis of Burkholderia pseudomallei Infection in Patients with Community-Acquired Septicemia. CVI 14: 811-812 [Abstract] [Full Text]  
• Duangsonk, K., Gal, D., Mayo, M., Hart, C. A., Currie, B. J., Winstanley, C. (2006). Use of a Variable Amplicon Typing Scheme Reveals Considerable Variation in the Accessory Genomes of Isolates of Burkholderia pseudomallei. J. Clin. Microbiol. 44: 1323-1334 [Abstract] [Full Text]  
• Novak, R. T., Glass, M. B., Gee, J. E., Gal, D., Mayo, M. J., Currie, B. J., Wilkins, P. P. (2006). Development and Evaluation of a Real-Time PCR Assay Targeting the Type III Secretion System of Burkholderia pseudomallei. J. Clin. Microbiol. 44: 85-90 [Abstract] [Full Text]  
• GAL, D., MAYO, M., SPENCER, E., CHENG, A. C., CURRIE, B. J. (2005). APPLICATION OF A POLYMERASE CHAIN REACTION TO DETECT BURKHOLDERIA PSEUDOMALLEI IN CLINICAL SPECIMENS FROM PATIENTS WITH SUSPECTED MELIOIDOSIS. Am J Trop Med Hyg 73: 1162-1164 [Abstract] [Full Text]  
• Cheng, A. C., Currie, B. J. (2005). Melioidosis: Epidemiology, Pathophysiology, and Management. Clin. Microbiol. Rev. 18: 383-416 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF) An erratum has been published Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Smith-Vaughan, H. C. Articles by Currie, B. J. Search for Related Content PubMed PubMed Citation Articles by Smith-Vaughan, H. C. Articles by Currie, B. J.